BackCVS Health Overview
CVS Health Corp

CVS Health Target Price

Where could CVS trade next? Consensus target price: $110.

Get informed when a big investor buys or sells

+ Follow

Share Price

$94.91

Average Target Price

$109.8615.7% upside

21 analysts in the last 4 months

High: $126 | Low: $92

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06Robert W. BairdMichael Ha$10712.7% upsideOpen
2026-08-06UBSKevin Caliendo$12632.8% upsideOpen
2026-08-06Barclays$10813.8% upsideOpen
2026-07-24UBS$12228.5% upsideOpen
2026-07-14Truist FinancialDavid MacDonald$11824.3% upsideOpen
2026-07-13Wells Fargo$12329.6% upsideOpen
2026-07-09RBC Capital$11319.1% upsideOpen
2026-07-07Cantor Fitzgerald$11015.9% upsideOpen
2026-07-06HSBC$1038.5% upsideOpen
2026-06-08Mizuho Securities$11521.2% upsideOpen
2026-06-04Morgan Stanley$11117% upsideOpen
2026-06-01Truist Financial$10813.8% upsideOpen
2026-06-01Piper SandlerJessica Tassan$11319.1% upsideOpen
2026-05-26BarclaysAndrew Mok$10611.7% upsideOpen
2026-05-20Mizuho Securities$11015.9% upsideOpen
2026-05-14Morgan Stanley$10611.7% upsideOpen
2026-05-13Bernstein$10611.7% upsideOpen
2026-05-07RBC Capital$10712.7% upsideOpen
2026-05-07Deutsche Bank$923.1% downsideOpen
2026-05-07Truist Financial$1027.5% upsideOpen
2026-05-07BarclaysAndrew Mok$1016.4% upsideOpen
2026-04-15Robert W. Baird$941% downsideOpen
2026-03-05Leerink PartnersMichael Cherny$983.3% upsideOpen
2026-01-28Argus Research$905.2% downsideOpen
2026-01-06Bernstein$914.1% downsideOpen
2025-12-12Bernstein$878.3% downsideOpen
2025-12-10Mizuho SecuritiesAnn Hynes$950.1% upsideOpen
2025-12-10Robert W. Baird$923.1% downsideOpen
2025-12-10Piper SandlerJessica Tassan$1016.4% upsideOpen
2025-12-10Morgan Stanley$932% downsideOpen
2025-12-10Barclays$932% downsideOpen
2025-12-10UBSKevin Caliendo$972.2% upsideOpen
2025-12-10Truist Financial$1005.4% upsideOpen
2025-12-04Bernstein$869.4% downsideOpen
2025-10-30RBC Capital$932% downsideOpen
2025-10-24UBS$961.1% upsideOpen
2025-10-14Truist FinancialDavid MacDonald$923.1% downsideOpen
2025-10-14Morgan StanleyErin Wright$896.2% downsideOpen
2025-10-14Goldman Sachs$914.1% downsideOpen
2025-10-09Mizuho SecuritiesAnn Hynes$887.3% downsideOpen
2025-10-07Wells Fargo$1038.5% upsideOpen
2025-09-04BarclaysAndrew Mok$878.3% downsideOpen
2025-08-18UBSKevin Caliendo$7916.8% downsideOpen
2025-08-14Robert W. BairdMichael Ha$8213.6% downsideOpen
2025-06-02BarclaysAndrew Mok$7916.8% downsideOpen
2025-02-18Argus Research$7718.9% downsideOpen
2024-12-03Deutsche BankGeorge Hill$6630.5% downsideOpen
2024-11-18Wells FargoStephen Baxter$6630.5% downsideOpen
2024-10-24Mizuho SecuritiesAnn Hynes$6630.5% downsideOpen
2024-10-21Truist FinancialDavid MacDonald$7619.9% downsideOpen

CVS Health (CVS) FAQ

As of the most recent data, CVS shows a target price of $110. Scroll down for historical charts and peer comparison views.

If CVS Health moved to the average analyst target of $110, shares would be roughly 15.7% higher than $94.91. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of CVS Health's earnings trajectory.

Besides this target price page, Stockcircle has CVS Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $110) with ownership activity and broader fundamentals.

CVS Health's target price is $110; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.